These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38640719)

  • 1. Synthesis and preclinical evaluation of a novel probe [
    Mo C; Sun P; Liang H; Chen Z; Wang M; Fu L; Huang S; Tang G
    Bioorg Chem; 2024 Jun; 147():107352. PubMed ID: 38640719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofluorinated GPC3-Binding Peptides for PET Imaging of Hepatocellular Carcinoma.
    Li Y; Zhang J; Gu J; Hu K; Huang S; Conti PS; Wu H; Chen K
    Mol Imaging Biol; 2020 Feb; 22(1):134-143. PubMed ID: 31044341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Evaluation of [
    Huang J; Bai L; Shi D; Jiang W; Chen P; Dong Y; Zhang X; Peng J; Hou J; Lu Y; Huang X; Tang G; Huang S
    Mol Pharm; 2024 May; 21(5):2425-2434. PubMed ID: 38554143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging the expression of glypican-3 in hepatocellular carcinoma by PET.
    Wang Z; Han YJ; Huang S; Wang M; Zhou WL; Li HS; Wang QS; Wu HB
    Amino Acids; 2018 Feb; 50(2):309-320. PubMed ID: 29204748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of Al[
    Sun P; Han Y; Hu K; Huang S; Wang M; Zhou K; Fu L; Chen H; Tang G
    Bioorg Chem; 2022 May; 122():105682. PubMed ID: 35278777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Preclinical Evaluation of [
    Liang H; Chen Z; Mo C; Tang G
    J Labelled Comp Radiopharm; 2024 Aug; 67(10):334-340. PubMed ID: 39041590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syntheses and preliminary evaluation of [(18) F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma.
    Li Y; Zhang D; Shi Y; Guo Z; Wu X; Ren JL; Zhang X; Wu H
    Contrast Media Mol Imaging; 2016 Jul; 11(4):262-71. PubMed ID: 26931574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated Synthesis and Preclinical Evaluation of Optimized Integrin α6-Targeted Positron Emission Tomography Imaging of Pancreatic Cancer.
    Chen L; Fu H; He H; Lou K; Li Q; Ye J; Feng G; Yu C
    Mol Pharm; 2023 Aug; 20(8):4277-4284. PubMed ID: 37463487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET imaging of CXCR4 expression using [
    Cheng K; Wang S; Liu T; Pei J; Wang S; Liu J; Zhao K; Luo Y; Xu S; Yu J; Liu J
    Theranostics; 2024; 14(16):6337-6349. PubMed ID: 39431004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of renal clearance of [
    Liu J; Guo X; Wen L; Wang L; Liu F; Song G; Zhu H; Zhou N; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2775-2786. PubMed ID: 37093312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [
    Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of a Glypican-3-specific binding peptide using
    Qin Y; Cheng S; Li Y; Zou S; Chen M; Zhu D; Gao S; Wu H; Zhu L; Zhu X
    Biomater Sci; 2020 Oct; 8(20):5656-5665. PubMed ID: 32896851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glypican-3-targeting F(ab')2 for 89Zr PET of hepatocellular carcinoma.
    Sham JG; Kievit FM; Grierson JR; Chiarelli PA; Miyaoka RS; Zhang M; Yeung RS; Minoshima S; Park JO
    J Nucl Med; 2014 Dec; 55(12):2032-7. PubMed ID: 25359880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Efficient Method for Labeling Single Domain Antibody Fragments with
    Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
    Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological evaluation of a novel stable peptide PET molecular probe [
    Yao B; Wang L; Xie C; Li M; Peng C; Li Z; Lu W; Chen J
    Nucl Med Biol; 2023; 118-119():108330. PubMed ID: 36889247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second generation Al
    Spahn MA; Luyten K; Van Loy T; Sathekge M; Deroose CM; Koole M; Schols D; Vanduffel W; De Vos K; Annaert P; Bormans G; Cleeren F
    Nucl Med Biol; 2024; 132-133():108906. PubMed ID: 38518400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and preclinical evaluation of a novel molecular probe [
    Sun P; Mo C; Bai L; Wang M; Chen Z; Zhang M; Han Y; Liang H; Tang G
    Bioorg Chem; 2024 Apr; 145():107193. PubMed ID: 38442611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy.
    Zhu S; Liang B; Zhou Y; Chen Y; Fu J; Qiu L; Lin J
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):625-640. PubMed ID: 37878029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.